Neurology:脑静脉血栓形成的急性症状性发作

2020-08-06 MedSci原创 MedSci原创

1/3的CVT患者会发生ASS,并与脑实质病变和血栓形成有关。研究人员发现ASS与患者结局之间没有关联。

近日,神经病学领域权威杂志Neurology上发表了一篇研究文章,该研究旨在明确脑静脉血栓形成(CVT)患者急性症状性发作(ASS)的特征、预测因素和结局,研究人员调查了国际CVT联盟内12家医院的1281例连续就诊的CVT成年患者。

研究人员将ASS定义为症状发作至CVT诊断后7天之间的任何发作,并将ASS分为诊断前ASS和诊断后ASS。癫痫持续状态(SE)也进行了单独分析。研究人员分析了ASS的预测因素,以及采用多变量logistic回归分析了ASS与临床结局(改良的Rankin量表)之间的关联。

在1281名符合条件的患者中,441名(34%)患者伴有ASS。ASS的基线预测指标为脑出血([ICH],调整后比值比[aOR]为4.1,95%置信区间[CI]为3.0-5.5)、无ICH的脑水肿/梗塞(aOR为2.8,95%CI为2.0-4.0)、皮层静脉血栓形成(aOR为2.1,95%CI为1.5-2.9)、矢状上窦血栓形成(aOR为2.0,95%CI为1.5-2.6)、局灶性神经功能缺损(aOR为1.9,95%CI为1.4-2.6)、颅底蛛网膜下腔出血(aOR为1.6,95%CI为1.1-2.5)和女性特异性危险因素(aOR为1.5,95%CI为1.1-2.1)。93例患者(7%)仅在诊断后出现ASS,最好通过皮质静脉血栓形成进行预测(阳性/阴性预测值为22%/92%)。80名(6%)患者伴有SE,可通过ICH、局灶性神经功能缺损和脑水肿/梗塞独立预测。ASS和SE均与患者结局无关。

由此可见,1/3的CVT患者会发生ASS,并与脑实质病变和血栓形成有关。研究人员发现ASS与患者结局之间没有关联。

原始出处:

Erik Lindgren.et al.Acute symptomatic seizures in cerebral venous thrombosis.Neurology.2020.https://doi.org/10.1212/WNL.0000000000010577

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1698131, encodeId=9ee116981312d, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Fri May 14 01:28:08 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001096, encodeId=21d720010961b, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Jun 08 04:28:08 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955501, encodeId=52191955501c3, content=<a href='/topic/show?id=0aeb991e44c' target=_blank style='color:#2F92EE;'>#静脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99174, encryptionId=0aeb991e44c, topicName=静脉血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Sun Oct 11 11:28:08 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483293, encodeId=81721483293cc, content=<a href='/topic/show?id=c82e991e71b' target=_blank style='color:#2F92EE;'>#静脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99177, encryptionId=c82e991e71b, topicName=静脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d387907505, createdName=ms5187542471278033, createdTime=Sat Aug 08 11:28:08 CST 2020, time=2020-08-08, status=1, ipAttribution=)]
    2021-05-14 fusion
  2. [GetPortalCommentsPageByObjectIdResponse(id=1698131, encodeId=9ee116981312d, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Fri May 14 01:28:08 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001096, encodeId=21d720010961b, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Jun 08 04:28:08 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955501, encodeId=52191955501c3, content=<a href='/topic/show?id=0aeb991e44c' target=_blank style='color:#2F92EE;'>#静脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99174, encryptionId=0aeb991e44c, topicName=静脉血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Sun Oct 11 11:28:08 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483293, encodeId=81721483293cc, content=<a href='/topic/show?id=c82e991e71b' target=_blank style='color:#2F92EE;'>#静脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99177, encryptionId=c82e991e71b, topicName=静脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d387907505, createdName=ms5187542471278033, createdTime=Sat Aug 08 11:28:08 CST 2020, time=2020-08-08, status=1, ipAttribution=)]
    2021-06-08 yinhl1978
  3. [GetPortalCommentsPageByObjectIdResponse(id=1698131, encodeId=9ee116981312d, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Fri May 14 01:28:08 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001096, encodeId=21d720010961b, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Jun 08 04:28:08 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955501, encodeId=52191955501c3, content=<a href='/topic/show?id=0aeb991e44c' target=_blank style='color:#2F92EE;'>#静脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99174, encryptionId=0aeb991e44c, topicName=静脉血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Sun Oct 11 11:28:08 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483293, encodeId=81721483293cc, content=<a href='/topic/show?id=c82e991e71b' target=_blank style='color:#2F92EE;'>#静脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99177, encryptionId=c82e991e71b, topicName=静脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d387907505, createdName=ms5187542471278033, createdTime=Sat Aug 08 11:28:08 CST 2020, time=2020-08-08, status=1, ipAttribution=)]
    2020-10-11 xue8602
  4. [GetPortalCommentsPageByObjectIdResponse(id=1698131, encodeId=9ee116981312d, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Fri May 14 01:28:08 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001096, encodeId=21d720010961b, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Jun 08 04:28:08 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955501, encodeId=52191955501c3, content=<a href='/topic/show?id=0aeb991e44c' target=_blank style='color:#2F92EE;'>#静脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99174, encryptionId=0aeb991e44c, topicName=静脉血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Sun Oct 11 11:28:08 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483293, encodeId=81721483293cc, content=<a href='/topic/show?id=c82e991e71b' target=_blank style='color:#2F92EE;'>#静脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99177, encryptionId=c82e991e71b, topicName=静脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d387907505, createdName=ms5187542471278033, createdTime=Sat Aug 08 11:28:08 CST 2020, time=2020-08-08, status=1, ipAttribution=)]

相关资讯

Stroke:急诊脑静脉血栓形成的误诊分析!

由此可见,在一个大型的、异质的多状态队列中,30例患者中有1例可能出现CVT误诊,但与不良临床结局无关。

Stroke:脑静脉血栓形成的再通

由此可见,接受抗凝治疗的患者的再通率总体上高达85%,未进行静脉再通与较差的临床结局相关。

Stroke:脑静脉血栓形成后发生肺栓塞的风险如何?

由此可见,CVT后发生PE的风险明显低于DV后发生PE的风险。在CVT患者中,住院期间发生PE的风险最大。

Stroke:产后期是脑静脉血栓形成的危险因素

由此可见,最近分娩的女性患CVT的风险增加,而怀孕期间CVT的风险似乎并未增加。

欧洲卒中组织脑静脉血栓形成诊断和治疗指南

目前的脑静脉血栓形成(cerebral venous thrombosis,CVT)诊断和管理指南由2010 年欧洲神经病学联盟和2011 年美国心脏学会和美国卒中学会制定。上述指南依据传统方法,结合具有科学证据的综述和专家意见,然后用矩阵模型结合推荐意见分类和关于证据分级系统,对证据和推荐意见进行分类。2010 -2011 年以来,CVT 的诊断和管理已经在多方面积累了新的证据。笔者的目的是用更

J Thromb Haemost:再通对脑静脉血栓形成长期神经学结局的影响!

由此可见,大多数首次CVT患者在随访期间完全或部分再通。再通与有利的神经学结局独立相关的。